Spots Global Cancer Trial Database for ced
Every month we try and update this database with for ced cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Topotecan Using Convection-Enhanced Delivery (CED) in High Grade Glioma | NCT02278510 | Malignant Gliom... WHO Grade III o... | Topotecan Gadolinium DTPA Cleveland Multi... | 18 Years - | Case Comprehensive Cancer Center | |
D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients | NCT05734560 | Newly Diagnosed... | D2C7-IT 2141-V11 | 18 Years - | Duke University |